1. Braun aren’t using the cloud or SaaS, hence you haven’t seen it. It’s been said umpteen times they are negotiating that style of revenue now with Beurer
2. FDA approval - LSH wouldn’t be funding it for a start, as they’ve elluded to the Israeli group is in talks to provide funding. As for getting to final stages, again so what ? There are stocks worth $300-500M waiting FDA approval and no revenue, it’s all about the deal
3. Extremely hard for this stock to break above 15c ... hilarious !
You were cheering this at 30c when it didn’t have the platform complete and no weed exposure, now with braun backing them, a vape prototype due out in a month and Israeli group mulling clinical trials you are talking it down as much as possible and making out like the next quarterly figures are make or break ...
LSH Price at posting:
11.5¢ Sentiment: Buy Disclosure: Held
